Canagliflozin and Metformin Extended-Release Tablets and Larotrectinib Capsules
Determining the interaction of Canagliflozin and Metformin Extended-Release Tablets and Larotrectinib Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canagliflozin / metformin
Brand name: Invokamet, Invokamet XR
Synonyms: Canagliflozin and metformin, Canagliflozin and Metformin
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canagliflozin and Metformin Extended-Release Tablets-Larotrectinib Oral Solution
- Canagliflozin and Metformin Extended-Release Tablets-Larotrectinib Sulfate
- Canagliflozin and Metformin Extended-Release Tablets-Lartruvo
- Canagliflozin and Metformin Extended-Release Tablets-Larynex
- Canagliflozin and Metformin Extended-Release Tablets-Laryng-O-Jet
- Canagliflozin and Metformin Extended-Release Tablets-Laryngesic
- Larotrectinib Capsules-Canagliflozin and Metformin Tablets
- Larotrectinib Capsules-Canakinumab
- Larotrectinib Capsules-Canakinumab Subcutaneous
- Larotrectinib Capsules-Canasa
- Larotrectinib Capsules-Canasa Pac rectal
- Larotrectinib Capsules-Canasa rectal